Related Experiment Video
Updated: Sep 19, 2025
08:50
Predictive Immune Modeling of Solid Tumors
Published on: February 25, 2020
7.1K
Genetic Subtype-Based International Prognostic Index Prognostic Model in Diffuse Large B-Cell Lymphoma
Lan Mi1, Jili Deng2, Jiayue Qin3
1Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education) Department of Lymphoma Peking University Cancer Hospital & Institute Beijing China.
Medcomm
|June 18, 2025
Summary
A new integrated prognostic model for diffuse large B-cell lymphoma (DLBCL) combines molecular subtypes and clinical factors. This model improves survival prediction accuracy compared to existing methods, aiding treatment decisions.
Area of Science:
- Hematology
- Oncology
- Genomics
Background:
- Molecular subtyping aids drug selection in diffuse large B-cell lymphoma (DLBCL).
- An integrated prognostic model combining molecular and clinical features for DLBCL is lacking.
Purpose of the Study:
- To develop and validate an integrated prognostic model for DLBCL.
- To improve prognostic accuracy and guide clinical treatment decisions.
Main Methods:
- Retrospective analysis of whole genome sequencing, whole exome sequencing, and FISH in DLBCL patients.
- Development of a simplified LymphType algorithm.
- Integration of molecular subtypes and International Prognostic Index (IPI) into a novel prognostic model.
- Validation in an in-house cohort (N=100) and three public cohorts (N=1480).
Main Results:
- The integrated model demonstrated superior discrimination of overall survival (concordance index 0.773) compared to IPI (0.724) and classification algorithm alone (0.648).
- A four-category risk model (low, low-intermediate, high-intermediate, high) showed significant prognostic separation across all endpoints (p < 0.001).
- The model was validated in both in-house and public cohorts.
Conclusions:
- The proposed integrated prognostic stratification system offers accurate prognosis assessment for DLBCL.
- This system provides a foundation for personalized follow-up treatment strategies in DLBCL patients.
